Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery

Santiago Garcia1, Nicholas Marston, Yader Sandoval

  • 1Department of Medicine, Division of Cardiology, Minneapolis VA Medical Center and University of Minnesota, Minneapolis, MN 55417, USA. garci205@umn.edu

Journal of Vascular Surgery
|September 15, 2012
PubMed

Insights

Electrocardiographic (ECG) changes do not predict long-term mortality after vascular surgery when cardiac troponin (cTn) levels are elevated. Routine cTn surveillance aids in detecting cardiac events and stratifying risk post-surgery.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Biomarker Analysis

Background:

  • Postoperative cardiac events are a significant concern in vascular surgery patients.
  • Risk stratification is crucial for improving patient outcomes.
  • Electrocardiographic (ECG) changes and cardiac troponin (cTn) levels are used to assess cardiac risk.

Purpose of the Study:

  • To evaluate if ischemic ECG changes provide additional prognostic information on long-term mortality risk compared to peak troponin levels post-vascular surgery.
  • To determine the independent predictors of long-term mortality in patients undergoing vascular surgery.

Main Methods:

  • Retrospective analysis of 337 patients undergoing moderate-to-high-risk vascular surgery.
  • Categorization of peak cardiac troponin I (cTnI) levels as low-positive or high-positive.
  • Classification of ECGs as ischemic or nonischemic.
  • Cox proportional hazards regression analysis to identify predictors of 1-year mortality.

Main Results:

  • Elevated cTnI levels were associated with increased 1-year mortality (11% for low-positive, 17% for high-positive).
  • Age, stratified troponin levels, tissue loss, Revised Cardiac Risk Index, and statin use were independent predictors of mortality.
  • Ischemia on ECG was not found to be an independent predictor of long-term mortality.

Conclusions:

  • Elevated cTnI levels are more significant than ECG findings for predicting long-term mortality after vascular surgery.
  • Routine surveillance of cTn levels is recommended for cardiac event detection and risk stratification post-vascular surgery.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...